Fecal microbiota tx feasible for recurrent C. difficile in HIV

Fecal microbiota tx feasible for recurrent <i>C. difficile</i> in HIV
For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Internal Medicine.

(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Internal Medicine.

Latesha Elopre, M.D., and Martin Rodriguez, M.D., from the University of Alabama at Birmingham, describe two cases of fecal microbiota therapy in HIV-infected individuals—a 48-year-old man with AIDS receiving highly-active antiretroviral therapy and a 48-year- old woman with and AIDS receiving highly-active antiretroviral therapy. The first patient presented with recurrent diarrhea for eight months secondary to C. difficile infection and consented to fecal microbiota therapy after five relapses. The second patient was hospitalized for recurrent C. difficile infection and consented to fecal therapy after repeated recurrences following discontinuation of vancomycin therapy.

The researchers found that the day after administration of the the diarrhea and abdominal pain resolved for the first patient, and the diarrhea decreased for the second patient. During five years of follow-up, the first patient experienced no recurrences, while the second patient had no further recurrences during six weeks of follow-up.

"On the basis of our experience, we believe that fecal microbiota therapy should be considered in other HIV-infected patients who have recurrent episodes of C. difficile infection that do not respond to standard therapy," the authors write.

One author disclosed to Merck.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Condoms 'too small' for Uganda men

Sep 19, 2014

Ugandan MPs have been inundated with complaints that many condoms on sale in the east African nation are too small, warning the problem is a blow to the fight against AIDS.

Withdrawal from the evolutionary race

Sep 18, 2014

In some HIV sufferers, the immune system does not fight off the immune deficiency virus. Instead, the body tolerates the pathogen. A research team headed by ETH Zurich has now determined how strongly patients ...

The genetics of coping with HIV

Sep 16, 2014

We respond to infections in two fundamental ways. One, which has been the subject of intensive research over the years, is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another, which ...

User comments